CAJ | 학술논문

目的：探讨奥扎格雷钠联合巴曲酶治疗进展性脑梗死的疗效观察。方法：回顾性分析我院收治的进展性脑梗死患者70例的临床资料，随机分为对照组和观察组，各36例，对照组给予奥扎格雷钠治疗，观察组给予奥扎格雷钠联合巴曲酶治疗，均治疗14d。疗程结束后，观察两组的临床疗效、第7、14d神经功能缺损评分情况及其不良反应。结果：总有效率：观察组显著优于对照组(P＜0.05)。两组患者治疗第7d、第14d神经功能缺损评分与治疗前比较，显著低于治疗前(P＜0.05)；观察组治疗第7d、第14d神经功能缺损评分显著低于对照组(P＜0.05)。两组患者均未出现不良反应。结论：奥扎格雷钠与巴曲酶联合应用在治疗进展性脑梗死效果显著，安全性高，不良反应低。
목적：탐토오찰격뢰납연합파곡매치료진전성뇌경사적료효관찰。방법：회고성분석아원수치적진전성뇌경사환자70례적림상자료，수궤분위대조조화관찰조，각36례，대조조급여오찰격뢰납치료，관찰조급여오찰격뢰납연합파곡매치료，균치료14d。료정결속후，관찰량조적림상료효、제7、14d신경공능결손평분정황급기불량반응。결과：총유효솔：관찰조현저우우대조조(P＜0.05)。량조환자치료제7d、제14d신경공능결손평분여치료전비교，현저저우치료전(P＜0.05)；관찰조치료제7d、제14d신경공능결손평분현저저우대조조(P＜0.05)。량조환자균미출현불량반응。결론：오찰격뢰납여파곡매연합응용재치료진전성뇌경사효과현저，안전성고，불량반응저。
[ABSTRACT]Objective:To investigate the efifcacy of enzyme treatment of progressive cerebral infarction ozagrel joint Palestinian song. Methods:The clinical data of progressive cerebral infarction 70 cases of patients retrospectively in our hospital, Randomly divided into control group and observation group, the two groups were each 36 cases, in the control group were given ozagrel treatment, observation group was given ozagrel joint Batroxobin, were treated for 14d. After the treatment, the clinical efifcacy was observed between the two groups, the ifrst 7,14d neurological function and its adverse reactions. Results:The total effective rate:observation group was signiifcantly bet er than the control group(P<0.05). Two groups of patients before the ifrst 7d, Section 14d neurological deifcits compared with before treatment was signiifcantly lower than the treatment (P<0.05);observation group therapy ifrst 7d, Section 14d neurological deifcit scores were signiifcantly lower than the control group(P<0.05). Two groups of patients were not adverse reactions. Conclusion:Ozagrel combined with batroxobin progress in the treatment of cerebral infarction effect is remarkable, safe, low side effects.